Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAF1 | P04049 | 1/20 | 0.33 |
| ▸ | RHEB | Q15382 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.31 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.30 |
| ▸ | SELE | P16581 | 1/20 | 0.30 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7884321 | 0.88 | RAF1 (0.35) | RAF1RHEBICAM1SELE | |
| SCHEMBL7873260 | 0.87 | SIRT2 (0.34) | RAF1RHEBICAM1SELE | |
| SCHEMBL7880782 | 0.87 | RHEB (0.32) | RAF1RHEBCHEK2 | |
| SCHEMBL7877449 | 0.86 | RHEB (0.39) | RAF1RHEBARCHEK2 | |
| SCHEMBL7880742 | 0.86 | SMN1; SMN2 (0.40) | RHEBCHEK2 | |
| SCHEMBL7884770 | 0.86 | RAF1 (0.34) | RAF1RHEB | |
| SCHEMBL7882100 | 0.86 | RHEB (0.38) | RAF1RHEBARCHEK2 | |
| SCHEMBL7873739 | 0.85 | RHEB (0.37) | RAF1RHEBARICAM1SELE | |
| SCHEMBL7878042 | 0.84 | RAF1 (0.33) | RAF1RHEB | |
| SCHEMBL7881901 | 0.83 | RHEB (0.41) | RAF1RHEBCHEK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6248772-B1 | HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS | SUMITOMO PHARMACEUTICALS CO., LTD. (JP) | 2001-06-19 | — | — | US | disclosed |
| US-6169107-B1 | USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS | SUMITOMO PHARMACEUTICAL CO., LTD. (JP) | 2001-01-02 | — | — | US | disclosed |
| EP-0708091-A2 | Indoloylguanidine derivatives | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1996-04-24 | — | — | EP | disclosed |